Antisense antiviral compound and method for treating arenavirus infection
AssigneeAVI BioPharma, Inc.
InventorsBenjamin Neuman, David A. Stein, Michael Buchmeier, Patrick L. Iversen
Life of this patent
Estimating the term…
Loading patent…
AssigneeAVI BioPharma, Inc.
InventorsBenjamin Neuman, David A. Stein, Michael Buchmeier, Patrick L. Iversen
Estimating the term…
The invention provides antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Arenaviridae family and in the treatment of a viral infection. The compounds are particularly useful in the treatment of Arenavirus infection in a mammal. The antisense antiviral compounds are substantially uncharged morpholino oligonucleotides have a sequence of 12-40 subunits, including at least 12 subunits having a targeting sequence that is complementary to a region associated with viral RNA sequences within a 19 nucleotide region of the 5′-terminal regions of the viral RNA, viral complementary RNA and/or mRNA identified by SEQ ID NO:1.
1-17. (canceled)
A method of inhibiting viral infection in mammalian cells by an Arenavirus in the Arenaviridae family, comprising
An antisense oligonucleotide compound comprised of morpholino subunits and phosphorous-containing intersubunit linkages having the following structure (I):
Dependencies are inferred from the claim text.